Company Profile

SHREE GANESH REMEDIES LTD.

NSE : NABSE : 540737ISIN CODE : INE414Y01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE390.30-11.3 (-2.81 % )
PREV CLOSE (Rs.) 401.60
OPEN PRICE (Rs.) 400.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5534
TODAY'S LOW / HIGH (Rs.)385.00 400.00
52 WK LOW / HIGH (Rs.) 76.43 461.4
NSE
This Company is not listed in NSE

Company News

Date Heading Details
01-Jun-2021 Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015, Regarding Development Of New Product Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015, regarding Development of New Product
27-May-2021 Shree Ganesh Remedies informs about announcement <p align="justify">Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shree Ganesh Remedies has informed that the company has successfully commissioned a new Plant No.3B at GIDC Ankleshwar, with an installed production capacity 54 KL (Kilo litres) working volumes for its existing products. The trial run of the plant was successfully completed on May 26, 2021 and the Company is expected to begin commercial production by early June, 2021. Further the commissioning of new Plant No.3B has been funded through internal accruals and the Company continues to be a 'Zero Debt Entity'.</p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>
27-May-2021 Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015
03-May-2021 Shree Ganesh Remedies board recommends final dividend <p align="justify">Shree Ganesh Remedies has informed that the Board of Directors of the Company at its meeting held on May 03, 2021, has recommended Final Dividend of Rs 1.75 per Equity Share of Face Value of Rs 10 each for the Financial Year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting of the Company.</p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>
03-May-2021 Shree Ganesh Remedies informs about outcome of board meeting <p align="justify">Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Schedule III to the said Regulations, Shree Ganesh Remedies has informed that the Board of Directors of the Company, at its Meeting held today, i.e., on Monday, May 03, 2021 (which commenced at 1l.00 a.m. and concluded at 11:45 am.), have approved/ noted the following: Audited Financial Results for the quarter and Financial year ended March 31, 2021, and recommendation of Final Dividend for the Financial Year 2020-21.</p><p align="justify">The above information is a part of company's filings submitted to BSE.</p>
03-May-2021 Board recommends Final Dividend Shree Ganesh Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 03, 2021, inter alia, has recommended Final Dividend of Rs. 1.75/ - (Rupee One and Paisa Seventy Five Only) per Equity Share of Face Value of Rs. 10/- (Rupees Ten Only) each for the Financial Year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting of the Company.
19-Apr-2021 Board Meeting Intimation for Notice Of Board Meeting Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2021 ,inter alia, to consider and approve In compliance of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that a meeting of the Board of Directors of the Company will be held on Monday, May 03, 2021 at the registered office of the Company to consider amongst other business, inter-alia, the following: 1. Approval of Audited Financial Results of the Company for the quarter and financial year ended on March 31, 2021. 2. Recommendation of Final Dividend on the Equity Shares, if any.
19-Apr-2021 Board to consider Final Dividend Shree Ganesh Remedies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 03, 2021, to consider amongst other business, inter-alia, the following: 1. Approval of Audited Financial Results of the Company for the qu arter and financial year ended on March 31, 2021. 2. Recommendation of Final Dividend on the Equity Shares, if any. In accordance to the Code of Conduct of the Company for prohibition of insider trading, th e "Trading Window" for dealing / trading in the shares of the Company was closed from April 01, 2021 and shall remain closed till 48 hours from the closure of the Board Meeting.
24-Nov-2020 Shree Ganesh Remedies gets nod for migrating Shares from SME platform to BSE <p align="justify">Shree Ganesh Remedies has received approval from BSE for migrating the 10,006,446 Equity Shares of the Company from SME platform to Main Board platform of BSE with effective from November 25, 2020. <p align="justify">Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. </p>